Chong Kun Dang Pharmaceutical (185750) — Free Cash Flow Generation Index
Chong Kun Dang Pharmaceutical (185750) has a Free Cash Flow Generation Index of -5.04x as of March 2026. Free cash flow of ₩-62.02 Billion represents -5% of operating cash flow (₩12.32 Billion). Explore Chong Kun Dang Pharmaceutical (185750) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Chong Kun Dang Pharmaceutical Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Chong Kun Dang Pharmaceutical across 10 annual periods. For the full cash flow conversion analysis, see Chong Kun Dang Pharmaceutical operating cash flow efficiency.
Annual Free Cash Flow Generation for Chong Kun Dang Pharmaceutical (2016–2025)
Year-by-year Free Cash Flow Generation Index for Chong Kun Dang Pharmaceutical. Check 185750 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.66x | ₩-111.77 Billion | ₩67.36 Billion | ₩179.13 Billion | ▼ -5783.4% |
| 2024 | -0.03x | ₩-1.81 Billion | ₩64.29 Billion | ₩66.10 Billion | ▼ -103.6% |
| 2023 | 0.78x | ₩249.35 Billion | ₩318.16 Billion | ₩68.81 Billion | ▲ +261.9% |
| 2022 | 0.22x | ₩14.67 Billion | ₩67.73 Billion | ₩44.90 Billion | ▲ +107.2% |
| 2021 | -3.02x | ₩-38.94 Billion | ₩12.90 Billion | ₩48.24 Billion | ▼ -566.4% |
| 2020 | 0.65x | ₩67.51 Billion | ₩104.32 Billion | ₩32.64 Billion | ▼ -4.6% |
| 2019 | 0.68x | ₩52.43 Billion | ₩77.29 Billion | ₩21.84 Billion | ▲ +60.8% |
| 2018 | 0.42x | ₩17.99 Billion | ₩42.63 Billion | ₩21.92 Billion | ▼ -42.9% |
| 2017 | 0.74x | ₩60.35 Billion | ₩81.67 Billion | ₩19.79 Billion | ▼ -56.1% |
| 2016 | 1.68x | ₩97.23 Billion | ₩57.79 Billion | ₩39.44 Billion | — |